Vertigo causes n treatment update..
Reading File
Finding Sources
Finding Sources
Searching PubMed
"Vertigo"[MeSH Terms] AND treatment
Searching the Web
2025 2026 vertigo BPPV vestibular migraine Meniere disease treatment guideline
Reading File
Finding Sources
Finding Sources
Searching the Web
AAO-HNS clinical practice guideline BPPV update vestibular suppressant recommendation canalith repositioning
Vertigo is a false sensation of spinning or movement. It is a symptom, not a diagnosis. Treatment depends on the cause, so identifying the pattern matters more than taking a “vertigo tablet.”
Seek emergency care now if vertigo is new and severe with:
- Weakness/numbness of face or limb, speech difficulty, double vision, severe imbalance, fainting
- New severe headache or neck pain
- Inability to walk, persistent vomiting/dehydration
- Chest pain, palpitations, or new hearing loss
These can signal a stroke or another urgent neurologic/cardiac cause. Central vertigo is more likely with persistent symptoms, neurologic signs, or vertical nystagmus. Textbook of Family Medicine, 9e, pp. 343-356.
Common causes and current treatment approach
| Likely cause | Typical clue | Main treatment |
|---|---|---|
| BPPV | Brief spinning, usually seconds, triggered by turning in bed, looking up, bending | Canal-repositioning maneuver, usually Epley for posterior-canal BPPV. This is first-line, not medication. |
| Vestibular neuritis | Sudden severe continuous vertigo for days, often after viral illness, no hearing loss | Short-term anti-nausea medication only if required, then early vestibular rehabilitation. Steroids may be considered early by a clinician, but benefit remains uncertain. |
| Labyrinthitis | Vertigo plus hearing loss/tinnitus, often after infection | Urgent clinical assessment, especially for sudden hearing loss; treatment depends on cause. |
| Ménière disease | Recurrent attacks lasting 20 min to hours with fluctuating hearing loss, tinnitus, ear fullness | ENT review, attack diary, lifestyle and trigger management; individualized preventive therapy. Vestibular rehabilitation is useful for persistent imbalance, not during an acute attack. |
| Vestibular migraine | Vertigo minutes to hours, migraine history or light/sound sensitivity, motion sensitivity | Sleep, regular meals, hydration, trigger management, vestibular rehab when needed; migraine preventive medicine may be prescribed if frequent. |
| Stroke/TIA or other central cause | Constant vertigo with neurologic symptoms or severe gait difficulty | Emergency assessment and brain/vascular evaluation. |
Key update for BPPV
For classic positional vertigo, guidelines emphasize a Dix-Hallpike assessment followed by a canalith repositioning procedure such as Epley. Routine brain imaging, vestibular testing, and routine use of meclizine/other antihistamines or benzodiazepines are discouraged when the presentation is clearly BPPV. The AAO-HNS BPPV guideline recommends reassessment within one month if symptoms persist.
Medicines: use sparingly
- Medicines such as meclizine, dimenhydrinate, prochlorperazine, or ondansetron can sometimes help severe nausea for a short period.
- They do not correct BPPV and may cause sedation, falls, blurred thinking, or delayed vestibular recovery when used for long periods.
- Benzodiazepines are generally avoided except in selected short-term, clinician-supervised situations.
- Do not drive, climb, or operate machinery while actively vertiginous or sedated.
Practical next steps
- Note episode duration: seconds, minutes-hours, or continuous days.
- Record triggers: head position, migraine symptoms, hearing changes, infection, new medication.
- Have a clinician examine eye movements, gait, hearing, orthostatic blood pressure, and perform positional testing if appropriate.
- If it is confirmed as BPPV, ask for a trained clinician or vestibular physiotherapist to perform the correct canal-specific maneuver. Avoid trying repeated home maneuvers until the affected canal/side is identified.
Recent evidence is evolving particularly for vestibular migraine. A 2025 systematic review compared preventive therapies, but drug choice still needs individual migraine history, comorbidities, pregnancy status, and adverse-effect risk (PMID: 41469852).
This is a shared conversation. Sign in to Orris to start your own chat.